Key facts
- This page summarizes Neil Desai's Form 4 filing for Aadi Bioscience, Inc. (WHWK).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Sep 2024, 17:55.
Neil Desai - 03 Sep 2024 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)
- Reporting relationship
- EXECUTIVE CHAIRMAN, Director
- Issuer ticker
- WHWK
- Reported as of
- 03 Sep 2024
- Net transaction value
- -$68,316
- SEC form
- 4
- Accepted by SEC
- 05 Sep 2024, 17:55:42 UTC
- Prior SEC filing
- 05 Aug 2024
- Next SEC filing
- 17 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Rodin, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Neil Desai filed Form 4 for Aadi Bioscience, Inc. (WHWK) on 05 Sep 2024.
Change
- Previous filing in this sequence was filed on 05 Aug 2024.
- Current net transaction value: -$68,316.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AADI
transaction
Common Stock
Sale
- Transaction value
- $68,316
- Shares
- -40,000
- Change %
- -3.3%
- Price
- $1.71
- Shares after
- 1,171,543
- Date
- 03 Sep 2024
- Ownership
- See footnote
- Footnotes
- F1, F2, F3
AADI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 639,698
- Date
- 03 Sep 2024
- Ownership
- See Footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.
Footnote F2
Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $1.63 to $1.82 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.
Footnote F4
Shares held by Anishka Irrevocable 2016 Trust dated October 19, 2016 (the "Irrevocable Trust"). The Reporting Person disclaims beneficial ownership of the shares held by the Irrevocable Trust except to the extent of any pecuniary interest therein, and this filing shall not be deemed an admission that Dr. Desai is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.